Hyaline Membrane Disease Assay
The Hyaline Membrane Disease Assay is a diagnostic device used to assess fetal lung maturity by measuring components in amniotic fluid or related specimens that indicate the risk of hyaline membrane disease (respiratory distress syndrome) in the newborn, typically used in the management of preterm labor. It is classified as a Class 3 (highest risk) device under FDA regulations, requiring Premarket Approval (PMA) given the critical clinical consequences of inaccurate assessment of neonatal lung maturity. The product code is LTC; no regulation number or specific medical specialty code is on file. No special flags apply to this device.
Research product code LTC in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- LTC
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- CH
- Submission Type
- 3
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K844637 | WHITESIDE ACRYLIC CEMENT SPACER SLEEVE | Jun 19, 1985 | Substantially Equivalent | Dow Corning Corp. Healthcare Industries Materials |